Literature DB >> 14969653

Interpretations of 'appropriate' minority inclusion in clinical research.

Giselle Corbie-Smith1, William C Miller, David F Ransohoff.   

Abstract

The range of possible interpretations of the phrase "appropriate representation" has left investigators struggling with the practical application of the National Institutes of Health guidelines on the inclusion of minorities in research. At least three goals might be reached by including minorities in clinical research: to test specific hypotheses about differences by race and ethnicity; to generate hypotheses about possible differences by race and ethnicity; and to ensure the just distribution of the benefits and burdens of participation in research, regardless of whether there are expected differences in outcome by race or ethnicity. In this paper, we describe possible interpretations of "appropriate representation," as well as provide a general approach that investigators might use to address this issue. To expand scientific knowledge about the health of minority populations, investigators should be expected to state which goal they have selected and why that goal is appropriate as compared with other possible goals.

Keywords:  Biomedical and Behavioral Research

Mesh:

Year:  2004        PMID: 14969653     DOI: 10.1016/j.amjmed.2003.09.032

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  14 in total

1.  Research participation by low-income and racial/ethnic minority groups: how payment may change the balance.

Authors:  Jennifer K Walter; James F Burke; Matthew M Davis
Journal:  Clin Transl Sci       Date:  2013-07-29       Impact factor: 4.689

2.  Policies to address disparities in clinical trials: the EDICT Project.

Authors:  Cynthia A Spiker; Armin D Weinberg
Journal:  J Cancer Educ       Date:  2009       Impact factor: 2.037

3.  From (Un)Willingness to InvolveMENt: Development of a Successful Study Brand for Recruitment of Diverse MSM to a Longitudinal HIV Research.

Authors:  Paula M Frew; Victoria A Williams; Eve T Shapiro; Travis Sanchez; Eli S Rosenberg; Vincent L Fenimore; Patrick S Sullivan
Journal:  Int J Popul Res       Date:  2013-11-21

4.  Effective recruitment strategies and community-based participatory research: community networks program centers' recruitment in cancer prevention studies.

Authors:  K Allen Greiner; Daniela B Friedman; Swann Arp Adams; Clement K Gwede; Paula Cupertino; Kimberly K Engelman; Cathy D Meade; James R Hébert
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-03       Impact factor: 4.254

5.  Participation of Asian-American women in cancer chemoprevention research: physician perspectives.

Authors:  Tung T Nguyen; Carol P Somkin; Yifei Ma
Journal:  Cancer       Date:  2005-12-15       Impact factor: 6.860

6.  Understanding bureaucracy in health science ethics: toward a better institutional review board.

Authors:  Barry Bozeman; Catherine Slade; Paul Hirsch
Journal:  Am J Public Health       Date:  2009-07-16       Impact factor: 9.308

7.  Variability in frontotemporal brain structure: the importance of recruitment of African Americans in neuroscience research.

Authors:  Nneka Isamah; Warachal Faison; Martha E Payne; James MacFall; David C Steffens; John L Beyer; K Ranga Krishnan; Warren D Taylor
Journal:  PLoS One       Date:  2010-10-26       Impact factor: 3.240

8.  The attitudes of females in drug court toward additional safeguards in HIV prevention research.

Authors:  James M DuBois; Catina Callahan O'Leary; Linda B Cottler
Journal:  Prev Sci       Date:  2009-12

9.  Patient Navigation As a Model to Increase Participation of African Americans in Cancer Clinical Trials.

Authors:  Mona N Fouad; Aras Acemgil; Sejong Bae; Andres Forero; Nedra Lisovicz; Michelle Y Martin; Gabriela R Oates; Edward E Partridge; Selwyn M Vickers
Journal:  J Oncol Pract       Date:  2016-05-17       Impact factor: 3.840

10.  Inclusion of women, minorities, and children in clinical trials: opinions of research ethics board administrators.

Authors:  Holly A Taylor
Journal:  J Empir Res Hum Res Ethics       Date:  2009-06       Impact factor: 1.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.